Literature DB >> 17556910

Cutaneous amyloidosis associated with primary biliary cirrhosis.

Jean R Tafarel1, Lara B Lemos, Patrícia M Oliveira, Valéria P Lanzoni, Maria L G Ferraz.   

Abstract

Primary cutaneous amyloidosis is defined as the deposition of amyloid in the skin in the absence of systemic involvement. The association between primary cutaneous amyloidosis and other diseases, although rare, has been documented for connective tissue disorders such as systemic sclerosis, systemic lupus erythematosus and rheumatoid arthritis. We report the case of a 41-year-old woman who developed primary biliary cirrhosis in association with primary cutaneous amyloidosis. This association has not been reported before in the literature.

Entities:  

Mesh:

Year:  2007        PMID: 17556910     DOI: 10.1097/MEG.0b013e32811ec024

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  4 in total

Review 1.  [Hereditary and non-hereditary cutaneous amyloidoses].

Authors:  S Schreml; J Schroeder; F Eder; R M Szeimies; M Landthaler; P Babilas
Journal:  Pathologe       Date:  2009-05       Impact factor: 1.011

2.  Primary cutaneous amyloidosis associated with autoimmune hepatitis-primary biliary cirrhosis overlap syndrome and Sjögren syndrome: A case report.

Authors:  Xin Yan; Jinglan Jin
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.889

3.  Clinicopathological Study of Primary Cutaneous Amyloidosis in a Tertiary Care Center of Eastern India Reveals Insignificant Association with Friction, Scrubbing, and Photo-Exposure: How valid is the "Keratinocyte Hypothesis"?

Authors:  Projna Biswas; Dayamay Pal; Abhishek De; Gobinda Chatterjee; Arghyaprasun Ghosh; Sudip Das; Pijush Kanti Das; Aarti Sarda; Sumit Sen
Journal:  Indian J Dermatol       Date:  2019 Jan-Feb       Impact factor: 1.494

Review 4.  Skin Manifestations Associated with Autoimmune Liver Diseases: a Systematic Review.

Authors:  Benedetta Terziroli Beretta-Piccoli; Pietro Invernizzi; M Eric Gershwin; Carlo Mainetti
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 10.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.